Colgate-Palmolive Co

Procter & Gamble (PG) posted stronger-than-expected third-quarter results on Tuesday, April 23.

Net sales in North America fell 5.0% in 1Q17, reflecting a strong decline in volumes coupled with lower pricing.

Lower pricing adversely impacted Procter & Gamble’s (PG) sales across product segments amid increased competitive activity.

Colgate-Palmolive (CL) has a market capitalization of $60.9 billion. CL rose by 0.37% to close at $68.23 per share as of March 10, 2016.

The Procter & Gamble Company, or P&G, is the largest household and personal products company in the world. It was established in 1837 by William Procter and James Gamble.

Procter & Gamble (PG) has a market cap of $224.1 billion. PG rose by 0.35% to close at $82.84 per share on March 3, 2016.

For distribution in the United States, Clorox (CLX) sells or markets its products primarily through mass retail outlets, e-commerce channels, wholesale distributors, and medical supply distributors.

Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

The 1Q16 margins of consumer packaged goods (or CPG) companies sent strong signals. These companies have been investing heavily in innovative products and other growth initiatives.

Colgate-Palmolive (CL) posted net sales of $3.8 billion, a decline of about 2% on a YoY (year-over-year) basis, as unfavorable currency rates hurt the top line by 5%.

A country’s net exports measure the value of total exports less the value of its total imports. It’s positive if exports are larger in value than imports.

Colgate’s worldwide gross profit margin fell to 58.5% in 2014 from 58.6% in 2013.

The COVID-19 pandemic boosted Clorox’s sales. People started paying more attention to cleaning and sanitizing.

Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.

Clorox stock rose 4.1% on March 16, even though the US stock market crashed amid the coronavirus pandemic. JPMorgan Chase upgraded its rating.

KushCo Holdings reported its Q1 earnings on January 8. KushCo reported revenue of $34.96 million, below analysts’ forecast of $41.5 million.

Although Church & Dwight stock is trading in the green, it has lagged its peers and the broader markets. The stock didn’t repeat its 2018 performance.

Procter & Gamble stock has generated a significant amount of wealth for investors this year. The company boosted shareholders’ returns.

Colgate-Palmolive released its third-quarter earnings results today. The company’s performance was mixed, irking investors.

After closing in the red yesterday, the US equity market was trading marginally higher today. The cannabis sector is also up—and here’s why.

Procter & Gamble stock trades at 24.7x its fiscal 2020 estimated core EPS of $4.85. The stock trades at 23.2x its fiscal 2021 estimated core EPS of $5.17.

Church & Dwight (CHD) stock has risen 9.5% on a YTD (year-to-date) basis as of September 13. However, the stock lags its peers by a wide margin.

Procter & Gamble stock benefits from its strong organic sales. On average, the company’s organic sales have increased by 5% in the last four quarters.

Clorox stock (CLX) is down about 8% since the company posted its third quarter of fiscal 2019 earnings on May 1.

Clorox (CLX) posted net sales of $1.55 billion, which fell short of Wall Street’s estimate of $1.57 billion.

The Consumer Staples Select Sector SPDR ETF (XLP) rose 10.5% in the first quarter of 2019.

Clorox (CLX) posted net sales of $1.47 billion during the second quarter.

Procter & Gamble (PG) stock trades at 20.8x its estimated fiscal 2019 EPS of $4.41, which doesn’t look attractive.

Colgate-Palmolive (CL) stock is down about 9.6% on a YTD (year-to-date) basis as of March 26, 2018.

Colgate-Palmolive (CL) witnessed improved volumes across several regions thanks to the improvement in volumes driven by new products supported by increased advertising.

As of November 24, 2017, Colgate-Palmolive (CL) stock was trading at a forward PE multiple of 24.0x, which is higher than its peers.

The majority of analysts providing recommendations on Colgate-Palmolive (CL) stock maintain a neutral outlook.

Procter & Gamble’s (PG) PE ratio of 25.1x compares to a sector average of 23.3x. The dividend yield of 3.0% compares to a sector average of 3.8%.

CL’s organic sales in its North American segment remained flat in 4Q16. Volume gains in toothpaste were offset by a fall in toothbrushes and liquid hand soap.

Analysts expect Colgate-Palmolive (CL) to post revenue of $3.8 billion in 1Q17, which would represent a YoY (year-over-year) growth of 0.8%.

Procter & Gamble (PG) is trying to boost its sales through a continued focus on innovation. It spent $1.9 billion on research and development in fiscal 2016.

Avon Products (AVP) has a market cap of $2.1 billion. It rose by 14.4% to close at $4.76 per share on August 2, 2016.

Consumer packaged goods (or CPG) companies are trading at higher valuations compared to the S&P 500 Index (IVV) (SPY) (VOO) and the Dow Jones Industrial Average (DIA).

Church & Dwight (CHD) has a market cap of $12.7 billion. It fell by 0.74% to close at $99.14 per share on June 13, 2016.

Colgate’s (CL) Asia segment’s net revenue decreased 2.3% to $0.6 billion in 1Q16.

Colgate-Palmolive’s global market share is ~45%. It is the leading toothpaste compared to Oral-B and Close-up, especially in emerging markets like India.

As of March 17, 2016, CPG companies were trading at higher valuations relative to the S&P 500 Index (SPY) and the Dow Jones Industrial Average (DIA).

Colgate’s (CL) revenue declined 7.5% to $3.9 billion in 4Q15. The reported revenue was negatively impacted by foreign exchange and divestitures.

CPG companies’ 3Q15 margins sent strong signals. They have been investing in innovative products and other growth initiatives. This is impacting their margins.

Clorox (CLX) has a strong research and development (or R&D) team and devotes significant resources and attention to product development.

Clorox’s Lifestyle segment’s revenue increased 1.5% to $1 billion in fiscal 2015 compared to $0.9 billion in fiscal 2014. The increase was primarily due to higher shipments in natural personal care.

The Cleaning segment contributed 32.3% to the total consolidated sales of Clorox, the highest among all the segments. The increase was primarily due to higher volume growth.

Clorox’s (CLX) SG&A expenses increased 5.3% in fiscal 2015 compared to fiscal 2014. The increase was primarily due to increased advertising and marketing programs.

In order to attract consumers in retail stores, Colgate has increased its commercial investment in advertising, promotions, trade spending, and creative brand building.

Colgate’s funding-the-growth technique is the key component of the company’s financial strategy, according to comments by Ian Cook, the company’s CEO.